Commercial Services · Miscellaneous Commercial Services · NSE: AXISCADES · data 2026-10-09
AXISCADES Technologies Ltd.
Health check: Average (4.2/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹2,082.3
Market cap
₹8,848 cr
P/E
246
P/B
—
ROE
10.4%
ROCE
15.4%
Debt / equity
0.53
Dividend yield
0.00%
1-year return
21.1%
52-week high
₹2,360
52-week low
₹1,063.3
Operating margin
9.9%
Growth
| Revenue (last 12 months) | ₹1,099 cr |
| Net profit (last 12 months) | ₹36 cr |
| Sales growth, 3 years (yearly) | 12.2% |
| Profit growth, 3 years (yearly) | — |
Chart patterns
- Double bottom — breakout (key level ₹2,030)
Similar companies
Syngene International Ltd. (SYNGENE) · Concord Biotech Ltd. (CONCORDBIO) · International Gemological Institute Ltd (IGIL) · RITES Ltd. (RITES) · SIS Limited (SIS)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open AXISCADES in NSE Scanner →